Literature DB >> 21934449

Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.

Barbara A Goff1, Jacqueline W Miller, Barbara Matthews, Katrina F Trivers, C Holly A Andrilla, Denise M Lishner, Laura-Mae Baldwin.   

Abstract

OBJECTIVE: To identify the factors associated with inclusion of a gynecologic oncologist in managing the care of a woman with suspected ovarian cancer.
METHODS: A vignette-based survey was mailed to 3,200 physicians aged 64 and younger who were randomly sampled from family physician, general internist, and obstetrician-gynecologist (ob-gyn) lists from the American Medical Association Physician Masterfile. The vignette described a 57-year-old woman with pain, bloating, and a suspicious right adnexal mass with ascites. Using multivariable analysis we evaluated patient, physician, and practice characteristics associated with a self-reported referral or inclusion of a gynecologic oncologist in the patient's care.
RESULTS: The response rate was 61.7%. After exclusions we included 569 ob-gyns, 591 family physicians, and 414 general internists. Gynecologic oncologist referral and consultation was self reported by 39.3% of family physicians and 51.0% of general internists (P=.01). Among ob-gyns, 33.7% indicated they would perform surgery and 66.3% recommended consultation or referral. Factors associated with not referring and consulting included patients having Medicaid insurance (family physicians), providers' weekly average number of patients being more than 91 (family physicians and general internists), male sex (family physicians), a rural practice location (general internists), and solo practice (general internists). Factors associated with primary surgical management for ob-gyns were small and remote rural practice locations and Census division.
CONCLUSION: When presented with a patient with a suspicious ovarian mass, the majority of primary care physicians do not self-report direct referral to a gynecologic oncologist. This may contribute to the high rates of noncomprehensive surgery for ovarian cancer patients in the United States. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2011        PMID: 21934449     DOI: 10.1097/AOG.0b013e31822dabc6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.

Authors:  Robert C Bast; Steven Skates; Anna Lokshin; Richard G Moore
Journal:  Int J Gynecol Cancer       Date:  2012-05       Impact factor: 3.437

2.  Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.

Authors:  Sherri L Stewart; Julie S Townsend; Mary C Puckett; Sun Hee Rim
Journal:  J Womens Health (Larchmt)       Date:  2016-03       Impact factor: 2.681

3.  Physicians' beliefs about effectiveness of cancer screening tests: a national survey of family physicians, general internists, and obstetrician-gynecologists.

Authors:  Jacqueline W Miller; Laura-Mae Baldwin; Barbara Matthews; Katrina F Trivers; C Holly Andrilla; Denise Lishner; Barbara A Goff
Journal:  Prev Med       Date:  2014-07-17       Impact factor: 4.018

4.  Guideline-inconsistent breast cancer screening for women over 50: a vignette-based survey.

Authors:  Hajar Kadivar; Barbara A Goff; William R Phillips; C Holly A Andrilla; Alfred O Berg; Laura-Mae Baldwin
Journal:  J Gen Intern Med       Date:  2013-08-14       Impact factor: 5.128

5.  Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.

Authors:  Sun Hee Rim; Shawn Hirsch; Cheryll C Thomas; Wendy R Brewster; Darryl Cooney; Trevor D Thompson; Sherri L Stewart
Journal:  World J Obstet Gynecol       Date:  2016-05-10

6.  Biomarkers and Strategies for Early Detection of Ovarian Cancer.

Authors:  Robert C Bast; Zhen Lu; Chae Young Han; Karen H Lu; Karen S Anderson; Charles W Drescher; Steven J Skates
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-13       Impact factor: 4.254

7.  Assessing Complex Emergency Management with Clinical Case-Vignettes: A Validation Study.

Authors:  Anne Rousseau; Patrick Rozenberg; Philippe Ravaud
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.